BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36611101)

  • 1. Detection and Diagnosis of Cardiac Amyloidosis in Egypt.
    Abdelghany M; Abdelhamid M; Allam A; El Etriby A; Hafez S; Ragy H; Sobhy M
    Cardiol Ther; 2023 Mar; 12(1):197-213. PubMed ID: 36611101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality imaging in cardiac amyloidosis: a primer for cardiologists.
    Jurcuţ R; Onciul S; Adam R; Stan C; Coriu D; Rapezzi C; Popescu BA
    Eur Heart J Cardiovasc Imaging; 2020 Aug; 21(8):833-844. PubMed ID: 32393965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
    Korosoglou G; Giusca S; André F; Aus dem Siepen F; Nunninger P; Kristen AV; Frey N
    Vasc Health Risk Manag; 2021; 17():661-673. PubMed ID: 34720583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
    Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
    Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Clues and Diagnostic Workup of Cardiac Amyloidosis.
    Gill SS; Fellin E; Stampke L; Zhao Y; Masri A
    Methodist Debakey Cardiovasc J; 2022; 18(2):36-46. PubMed ID: 35414856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment.
    Jerome S; Farrell MB; Warren J; Embry-Dierson M; Schockling EJ
    J Nucl Med Technol; 2023 Jun; 51(2):102-116. PubMed ID: 37268322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis.
    Sabbour H; Hasan KY; Al Badarin F; Alibazoglu H; Rivard AL; Romany I; Perlini S
    Front Cardiovasc Med; 2021; 8():644508. PubMed ID: 34262948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
    Di Giovanni B; Gustafson D; Delgado DH
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
    [No Abstract]   [Full Text] [Related]  

  • 12. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings.
    Vergaro G; Aimo A; Barison A; Genovesi D; Buda G; Passino C; Emdin M
    Eur J Prev Cardiol; 2020 Nov; 27(17):1806-1815. PubMed ID: 31581822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus.
    Chander Mohan J; Dalal J; Chopra VK; Narasimhan C; Kerkar P; Oomman A; Ray Fcsi S; Sharma AR; Dougall P; Simon S; Verma Drm A; Radhakrishnan V
    Indian Heart J; 2022; 74(6):441-449. PubMed ID: 36410415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).
    Yilmaz A; Bauersachs J; Bengel F; Büchel R; Kindermann I; Klingel K; Knebel F; Meder B; Morbach C; Nagel E; Schulze-Bahr E; Aus dem Siepen F; Frey N
    Clin Res Cardiol; 2021 Apr; 110(4):479-506. PubMed ID: 33459839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis-A Survey-Based Study.
    Stan C; Mititelu R; Adam RD; Jurcuţ R
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.
    Castaño A; Manson DK; Maurer MS; Bokhari S
    Curr Cardiovasc Risk Rep; 2017 Jun; 11():. PubMed ID: 29057029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac amyloidosis: state-of-the-art review.
    Bukhari S
    J Geriatr Cardiol; 2023 May; 20(5):361-375. PubMed ID: 37397865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.